Kendall Capital Management Viatris Inc Transaction History

Kendall Capital Management

$331 Million
Q4 2024

A detailed history of Kendall Capital Management transactions in Viatris Inc stock. As of the latest transaction made, Kendall Capital Management holds 226,025 shares of VTRS stock, worth $2.59 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

226,025

Previous 209,970 7.65%

Holding current value

$2.59 Million

Previous $2.44 Million 15.47%

% of portfolio

0.85%

Previous 0.77%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$11.32 - $13.37 $181,742 - $214,655	16,055 Added 7.65%	226,025 $2.81 Million
Q3 2024 Nov 08, 2024	BUY	$10.32 - $12.13 $100,104 - $117,661	9,700 Added 4.84%	209,970 $2.44 Million
Q2 2024 Aug 12, 2024	BUY	$10.05 - $12.02 $182,256 - $217,982	18,135 Added 9.96%	200,270 $2.13 Million
Q1 2024 May 10, 2024	BUY	$11.27 - $13.53 $176,093 - $211,406	15,625 Added 9.38%	182,135 $2.17 Million
Q4 2023 Jan 26, 2024	BUY	$8.77 - $10.85 $280,289 - $346,766	31,960 Added 23.75%	166,510 $1.8 Million
Q3 2023 Oct 31, 2023	BUY	$9.59 - $11.35 $243,528 - $288,221	25,394 Added 23.26%	134,550 $1.33 Million
Q2 2023 Jul 28, 2023	BUY	$9.02 - $10.29 $251,838 - $287,296	27,920 Added 34.37%	109,156 $1.09 Million
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $198,094 - $263,982	21,532 Added 36.06%	81,236 $781,000
Q4 2022 Jan 30, 2023	BUY	$8.72 - $11.56 $193,758 - $256,863	22,220 Added 59.28%	59,704 $665,000
Q3 2022 Nov 02, 2022	BUY	$8.48 - $11.13 $192,309 - $252,406	22,678 Added 153.17%	37,484 $319,000
Q2 2022 Jul 29, 2022	BUY	$9.95 - $12.27 $147,319 - $181,669	14,806 New	14,806 $155,000

Others Institutions Holding VTRS

# of Institutions

1,134

Shares Held

986M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Viatris Inc Transaction History